Vanessa Gómez‐Vallejo
Vanessa Gómez‐Vallejo publishes mostly in Radiology, Nuclear Medicine and Imaging, Molecular Biology and Organic Chemistry, on topics such as Radiopharmaceutical Chemistry and Applications, Nanoparticle-Based Drug Delivery and Medical Imaging Techniques and Applications.
- World rank
- #1,898,919 of 7,710,434 ranked researchers
- Rank in Spain
- #40,562 of 204,306
- Works
- 148
- Citations
- 4.1k
- Citations per work
- 27.5
What does Vanessa Gómez‐Vallejo research?
Vanessa Gómez‐Vallejo's work is mostly in Medicine (16%), Biochemistry, Genetics and Molecular Biology (11%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else7550.8%
- Life Sciences2516.9%
- Health Sciences2416.2%
- Medicine2416.2%
- Physical Sciences2416.1%
- Chemistry96.2%
- Materials Science95.9%
- Engineering64.0%
- 1Radiology, Nuclear Medicine and Imaging16% of their works
- 2Molecular Biology11% of their works
- 3Organic Chemistry6% of their works
- 4Biomaterials6% of their works
- 5Cellular and Molecular Neuroscience6% of their works
- 6Biomedical Engineering4% of their works
Research topics
- Radiopharmaceutical Chemistry and Applications
- Nanoparticle-Based Drug Delivery
- Medical Imaging Techniques and Applications
- Neuroscience and Neuropharmacology Research
- Boron Compounds in Chemistry
- Chemical Reactions and Isotopes
- Nanoplatforms for cancer theranostics
- Alzheimer's disease research and treatments
Which keywords describe Vanessa Gómez‐Vallejo's research?
The keywords of their largest research topics: Cancer Treatment, Nanoparticles, Tumor Targeting, PET Imaging, Radiopharmaceuticals, Medicinal Chemistry, Drug Delivery and Nanocarriers.
- Tau Pathology
- Photothermal Therapy
- Deuterium
- Carboranes
- Synaptic Plasticity
- PET/CT
- Nanocarriers
- Medicinal Chemistry
- PET Imaging
- Nanoparticles
- Cancer Treatment
- Tumor Targeting
- Radiopharmaceuticals
- Drug Delivery
- Imaging
- Neurotransmission
- Boron Neutron Capture Therapy
- Amyloid Hypothesis
- Drug Discovery
- Reactive Oxygen Species
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cancer Treatment412 topics
- Nanoparticles312 topics
- Tumor Targeting312 topics
- PET Imaging261 topic
- Radiopharmaceuticals261 topic
- Medicinal Chemistry242 topics
- Drug Delivery221 topic
- Nanocarriers221 topic
- Imaging171 topic
- PET/CT171 topic
- Neurotransmission161 topic
- Synaptic Plasticity161 topic
- Boron Neutron Capture Therapy151 topic
- Carboranes151 topic
- Amyloid Hypothesis91 topic
- Deuterium91 topic
- Drug Discovery91 topic
- Photothermal Therapy91 topic
- Reactive Oxygen Species91 topic
- Tau Pathology91 topic
Where does Vanessa Gómez‐Vallejo work?
Vanessa Gómez‐Vallejo's main affiliation in the publication record is CIC biomaGUNE, Spain.
How many publications and citations does Vanessa Gómez‐Vallejo have?
OpenAlex counts 148 works and 4,073 citations for Vanessa Gómez‐Vallejo, an h-index of 34, ranking #1,898,919 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Vanessa Gómez‐Vallejo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.